Business Context and Reporting Period
This Form 8-K is filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on April 19, 2021. The registrant is an emerging growth company incorporated in Delaware, with principal executive offices in Menlo Park, CA. The report addresses a regulatory compliance issue regarding the listing of its common stock (ATNF) and warrants (ATNFW) on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document is a current report focused on regulatory status rather than financial performance data.
Material Changes
The material event reported is the receipt of a notice from Nasdaq on April 16, 2021, stating the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1). This non-compliance is due to the failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2020.
Outlook, Risks, and Management Commentary
- Compliance Timeline: The Company has 60 calendar days from the notification date (until June 15, 2021) to file the 2020 Form 10-K.
- Extension Possibility: If the report is not filed by June 15, 2021, the Company may submit a plan to regain compliance. If accepted, Nasdaq may grant an extension of up to 180 days (until October 12, 2021).
- Delisting Risk: There is no assurance that Nasdaq will accept the compliance plan or that the Company will regain compliance within any extension period. Failure to comply will result in the delisting of the Company's common stock from the Nasdaq Capital Market.
- Current Trading Status: The notice has no immediate impact on the listing or trading of the Company's common stock.
- Management Action: Management states it is working diligently to finalize and file the 2020 Form 10-K as soon as possible.
Investor Verification Checklist
- Verify the filing status of the 2020 Form 10-K with the SEC.
- Monitor the June 15, 2021 deadline for the initial compliance filing.
- Check for any subsequent announcements regarding a submitted compliance plan or Nasdaq's decision on an extension.
- Confirm the continued trading status of ATNF and ATNFW on Nasdaq.